Indianapolis -- Federal health regulators have issued enforcement letters to Indianapolis' Eli Lilly and Co. and three other drugmakers for making inaccurate or incomplete statements while promoting their drugs.
The letter to Lilly, disclosed by the Food and Drug Administration on Tuesday, cites a print advertisement for antidepressant Cymbalta. The FDA said Lilly's ad did not adequately display information about the drug's side effects, which is required.
Source
Insider's view - Lilly should take a look at the new Seroquel ad and take a leaf out of AstraZeneca's book! LOL!
1 comment:
"YOU SHALL FIND THE TRUTH, and it will piss you off.
Aldous Huxley
Post a Comment